» Articles » PMID: 17651842

The "slow Coronary Flow" Phenomenon: Evidence of Preserved Coronary Flow Reserve Despite Increased Resting Microvascular Resistances

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2007 Jul 27
PMID 17651842
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The expression "slow coronary flow phenomenon" (SCFP) indicates a slow progression of the contrast seen at the coronary angiography in the absence of epicardial stenosis and/or of other conditions associated with decreased coronary flow velocity. While microvascular abnormalities are suspected to underlie the mechanism of SCFP, they have never been directly demonstrated.

Methods And Results: Fifteen anginal patients with a positive stress test and no evidence of epicardial lesions (obstructive coronary artery disease, coronary ectasia, or coronary spasm) were enrolled. In eight patients, the diagnosis of SCFP was made (TIMI frame count>average +2SD). All subjects underwent measurement of the coronary flow reserve (CFR) and the index of microvascular resistance (IMR) using an intracoronary thermodilution method (RADI medical systems). There was no difference between groups in age, cardiovascular risk factors, blood pressure and heart rate, coronary artery diameter and fractional flow reserve (an index of the presence of epicardial stenosis). At rest, microvascular resistances (mean transit timexdistal pressure) were significantly higher in the SCFP group (SCFP: 104+/-31 versus 53+/-27, P<0.01). Showing normal responsiveness to vasodilators, this difference was abolished after induction of hyperemia (SCFP group: 34+/-22; control: 22+/-15, P=ns); coronary flow reserve was normal in the subjects with the SCFP (3.6+/-1.6).

Conclusions: We provide the first human in vivo evidence that resting microvascular resistances are increased in patients with the SCFP. At the same time, showing an intact capacity to vasodilate, microvascular resistances were normal during hyperemia, and coronary flow reserve was not impaired in SCFP patients.

Citing Articles

TIMI Frame Count and Coronary Function in Women With Suspected Ischemia and Nonobstructed Coronary Arteries.

Paquin A, Muhyieddeen A, Wei J, Wiens G, Cui Y, Pepine C JACC Adv. 2025; 4(3):101611.

PMID: 39983610 PMC: 11889343. DOI: 10.1016/j.jacadv.2025.101611.


Comparative study of myocardial perfusion and coronary flow velocity reserve derived from adenosine triphosphate stress myocardial contrast echocardiography in coronary lesions with no/mild stenosis.

Liu X, Li C, Zhang Q, Meng Q, Zhang H, Li Z Front Cardiovasc Med. 2024; 11:1353736.

PMID: 39380633 PMC: 11460289. DOI: 10.3389/fcvm.2024.1353736.


Randomised Placebo-Controlled Pilot Trial Evaluating the Anti-Anginal Efficacy of Ticagrelor in Patients with Angina with Nonobstructive Coronary Arteries and Coronary Slow Flow Phenomenon.

Pasupathy S, Tavella R, Zeitz C, Edwards S, Worthley M, Arstall M J Clin Med. 2024; 13(17).

PMID: 39274447 PMC: 11395883. DOI: 10.3390/jcm13175235.


Comparison of the Effect of Non-HDL-C/HDL-C Ratio on Coronary Slow Flow with Other Non-Traditional Lipid Markers.

Toprak K, Karatas M, Kaplangoray M, Dursun A, Tascanov M, Altiparmak I Acta Cardiol Sin. 2024; 40(4):388-401.

PMID: 39045373 PMC: 11261365. DOI: 10.6515/ACS.202407_40(4).20240419A.


Epicardial fat volume is associated with primary coronary slow-flow phenomenon in patients with severe aortic stenosis undergoing transcatheter valve implantation.

Weferling M, Rolf A, Treiber J, Fischer-Rasokat U, Liebetrau C, Hamm C BMC Cardiovasc Disord. 2024; 24(1):253.

PMID: 38750455 PMC: 11097472. DOI: 10.1186/s12872-024-03927-7.